Summary

PRA Health Sciences (PRA) Early Development Services (EDS) has established a group of experts dedicated to early phase patient studies. Our innovative Patient Pharmacology Services (PPS) features a unique scientific/medical and operational model that enables us to conduct studies in patients with hepatic impairment following the same processes and guidelines that we apply to traditional Phase I or Phase IIa trials.

Register to download

Hepatic Impairment Studies in Early Development Services